FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

987911000001107: Repaglinide 500microgram tablets 30 tablet (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
21651101000001112 Repaglinide 500microgram tablets 30 tablet (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
21651201000001117 Repaglinide 500microgram tablets 30 tablet en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module


17 descendants. Search Descendants:

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Repaglinide 500microgram tablets 30 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Repaglinide 500microgram tablets 30 tablet Is a Virtual medicinal product pack true Inferred relationship Existential restriction modifier
Repaglinide 500microgram tablets 30 tablet Is pack of Product containing precisely repaglinide 500 microgram/1 each conventional release oral tablet false Inferred relationship Existential restriction modifier
Repaglinide 500microgram tablets 30 tablet Has active ingredient Repaglinide false Inferred relationship Existential restriction modifier
Repaglinide 500microgram tablets 30 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Repaglinide 500microgram tablets 30 tablet VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Repaglinide 500microgram tablets 30 tablet Has manufactured dose form Conventional release oral tablet false Inferred relationship Existential restriction modifier
Repaglinide 500microgram tablets 30 tablet Has VMP Product containing precisely repaglinide 500 microgram/1 each conventional release oral tablet true Inferred relationship Existential restriction modifier
Repaglinide 500microgram tablets 30 tablet Has specific active ingredient Repaglinide true Inferred relationship Existential restriction modifier
Repaglinide 500microgram tablets 30 tablet Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
NovoNorm 500microgram tablets (Novo Nordisk Pharmaceuticals Ltd) 30 tablet 2 x 15 tablets Is a True Repaglinide 500microgram tablets 30 tablet Inferred relationship Existential restriction modifier
Repaglinide 500microgram tablets (Rivopharm (UK) Ltd) 30 tablet 2 x 15 tablets Is a True Repaglinide 500microgram tablets 30 tablet Inferred relationship Existential restriction modifier
Prandin 0.5mg tablets (Novo Nordisk Ltd) 30 tablet 2 x 15 tablets Is a True Repaglinide 500microgram tablets 30 tablet Inferred relationship Existential restriction modifier
Repaglinide 500microgram tablets (Medihealth (Northern) Ltd) 30 tablet Is a True Repaglinide 500microgram tablets 30 tablet Inferred relationship Existential restriction modifier
Prandin 0.5mg tablets (Mawdsley-Brooks & Company Ltd) 30 tablet Is a True Repaglinide 500microgram tablets 30 tablet Inferred relationship Existential restriction modifier
Repaglinide 500microgram tablets (Teva UK Ltd) 30 tablet 3 x 10 tablets Is a True Repaglinide 500microgram tablets 30 tablet Inferred relationship Existential restriction modifier
Repaglinide 500microgram tablets (Actavis UK Ltd) 30 tablet 3 x 10 tablets Is a True Repaglinide 500microgram tablets 30 tablet Inferred relationship Existential restriction modifier
Enyglid 0.5mg tablets (Krka UK Ltd) 30 tablet 2 x 15 tablets Is a True Repaglinide 500microgram tablets 30 tablet Inferred relationship Existential restriction modifier
Repaglinide 500microgram tablets (Alliance Healthcare (Distribution) Ltd) 30 tablet 3 x 10 tablets Is a True Repaglinide 500microgram tablets 30 tablet Inferred relationship Existential restriction modifier
Repaglinide 500microgram tablets (A A H Pharmaceuticals Ltd) 30 tablet 3 x 10 tablets Is a True Repaglinide 500microgram tablets 30 tablet Inferred relationship Existential restriction modifier
Repaglinide 500microgram tablets (Creo Pharma Ltd) 30 tablet Is a True Repaglinide 500microgram tablets 30 tablet Inferred relationship Existential restriction modifier
Repaglinide 500microgram tablets (Accord Healthcare Ltd) 30 tablet Is a True Repaglinide 500microgram tablets 30 tablet Inferred relationship Existential restriction modifier
Repaglinide 500microgram tablets (Waymade Healthcare Plc) 30 tablet Is a True Repaglinide 500microgram tablets 30 tablet Inferred relationship Existential restriction modifier
Repaglinide 500microgram tablets (Aspire Pharma Ltd) 30 tablet 3 x 10 tablets Is a True Repaglinide 500microgram tablets 30 tablet Inferred relationship Existential restriction modifier
Repaglinide 500microgram tablets (DE Pharmaceuticals) 30 tablet Is a True Repaglinide 500microgram tablets 30 tablet Inferred relationship Existential restriction modifier
Repaglinide 500microgram tablets (Mawdsley-Brooks & Company Ltd) 30 tablet Is a True Repaglinide 500microgram tablets 30 tablet Inferred relationship Existential restriction modifier
Repaglinide 500microgram tablets (Viatris UK Healthcare Ltd) 30 tablet Is a True Repaglinide 500microgram tablets 30 tablet Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start